RxDoctor Payments Data

Dorisa Polk, MD

Obstetrics & Gynecology · Scottsbluff, NENPI 1205833027

Payments from drug & device makers

What this record shows

The money is spread across several categories — education (40.1%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. Intuitive Surgical accounts for 91.6% of it on its own, with 8 other manufacturers making up the rest. Reporting peaked in 2020 at $4,315 and has fallen 97.9% since, to $92 in 2025. Among obstetrics & gynecology clinicians in NE with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$7,484in general payments, 2019–2025

Across 49 payments — averaging $152.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Intuitive Surgical$7K
  • Bayer$334
  • AbbVie$141
  • Merck$35
  • Organon$34
  • Covidien LP$28
  • plus $60 from 3 others

What the payments were for

  • Speaking & faculty fees$2,50033%
  • Travel & lodging$1,26517%
  • Food & beverage$71910%
  • Education$3,00040%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$7,484 in reported general payments places this provider in the 90th percentile of 242 obstetrics & gynecology providers in Nebraska.

See all obstetrics & gynecology providers in Nebraska

Medicare billing

Part B allowed, 2024
$71,121
Medicare patients
205
Services billed
1,408

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Estradiol126$8,199
Clobetasol Propionate16$1,192
Metronidazole37$662
Levothyroxine Sodium17$257
Medroxyprogesterone Acetate21$236
Cephalexin11$186
Venlafaxine Hcl ErVenlafaxine Hcl11$174
Fluconazole15$161
Solifenacin Succinate11$150
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim14$51

Paid to pharmacies, not to this prescriber.

Other obstetrics & gynecology in Scottsbluff

See the full list for Nebraska

Where these figures come from

Is this you, or does something look wrong? →